Recent Finacing
Recent Raise
Wugen is a clinical-stage biotech developing off-the-shelf allogeneic cell therapies, including CD7-targeted CAR-T and memory NK (WU-NK-101), using gene-editing, feeder-free expansion, GMP fusion molecules, cryopreservation for outpatient distribution.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
